• COMPANY
    • LEADERSHIP
    • CAREERS
    • NIH GRANT SUPPORT
    • CONTACT US
  • TECHNOLOGY
  • APPLICATIONS
    • ALLOSTERIC TARGETS
    • SECONDARY SCREENING & MECHANISM OF ACTION
    • COMPLEX TARGETS
  • DRUG DISCOVERY SERVICES
    • Assay Development
    • Secondary Screening
    • TRUBIND AT WORK
      • PPI INTERACTIONS
      • TARGETING GPCRs
      • KINASE INTERACTIONS
  • PRODUCTS
  • LITERATURE
  • NEWS
  • EVENTS
    • On-Demand Presentations
    • Exhibitions
HOME APPLICATIONS COMPLEX TARGETS

Complex Targets

Back Scattering Interferometry (BSI) can be used to interrogate small molecule binding to any type of target, but because it is mass independent and conformation sensitive, it is uniquely suited to studying interactions with large, membrane bound and other complex targets that cannot be effectively characterized using other techniques, for example:

•   GPCRs

•  Ion channels
•  Receptor tyrosine kinases
•  Transporters

•  Transcription factors

•  Intra-membrane proteases

•  Contractile proteins

•  Fibrils

MSI scientists have worked on many complex target problems, developing robust, high-value assays on the BSI technology platform for a variety of clients. The following partial list provides some examples of the pharmaceutical client project targets we have worked on to date.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Please send us an email or give us a call at (615) 938-7050 in North America or +49 (171) 760-4450 in Europe
to find out how MSI can help accelerate your assay development and screening efforts.

APPLICATIONS

  • ALLOSTERIC TARGETS
  • SECONDARY SCREENING & MECHANISM OF ACTION
  • COMPLEX TARGETS

SLAS2015 Exhibition & Tutorial

Visit our booth #1619 and attend our Tuesday Tutorial on Conformation-Sensitive Assay Detection for Accelerated Drug Discovery Research. Learn about the superior analytical power of TruBind™ Back Scattering Interferometry (BSI) technology for molecular interaction studies.
LEARN MORE>

TRY A LOW-RISK, HIGH-RETURN DRUG DISCOVERY PROJECT

Take advantage of our success-based drug-target characterization services including ortho- and allosteric membrane bound proteins, receptors, ion channels, protein complexes — your toughest targets.

LEARN MORE>

© Copyright 2015 by Molecular Sensing, Inc.
  • /Terms of Use
  • /Privacy Policy